CHEK2 and ovarian carcinoma: Moreover, CHEK2 variants have been observed in individuals with endometrial and ovarian cancers, but the associated risk due to CHEK2 mutations is currently unclear (Einarsdóttir et al., 2007; Pennington et al., 2013).